Poniard Pharmaceuticals, Inc. PARD

Full chart Compare
Set alert

Price alert · PARD

All alert types
0.00 USD 0.00 (+0.00%)

At closeNov 2, 2026, 4:00 PM EST

0.0001 Day range 0.0001
0.00001 52-week range 0.0001
YTD
0.00%
1 year
0.00%

Revenue & Expenses

Other Income → Expenses: $330.00KExpenses → Selling, General & Admin: $5.95MExpenses → Research & Development: $10.20MExpenses → Other Operating Expenses: $4.93MExpenses → Interest Expense: $267.00KGross Profit → Expenses: $15.00KRevenue → Gross Profit: $15.00KNet Loss → Expenses: $21.00MOther Income$330.00KGross Profit$15.00KNet Loss$21.00MExpenses$21.34MSelling, General & Admin$5.95MResearch & Development$10.20MOther Operating Expenses$4.93MInterest Expense$267.00KRevenue$15.00K

Latest period ending Dec 31, 2010 · select a line to chart its full history

Annual income statement

PARD annual income statement
Fiscal yearFY 2010 Dec 31, 2010FY 2009 Dec 31, 2009FY 2008 Dec 31, 2008FY 2007 Dec 31, 2007FY 2006 Dec 31, 2006
26.74M42.98M49.16M35.35M21.23M
7.97M25.74M33.73M22.38M13.36M
17.14M14.70M15.43M13.08M7.55M
-26.74M-42.98M-49.16M-35.35M-21.23M
2.21M3.14M1.90M1.73M0
-30.05M-45.72M-48.56M-32.78M-23.29M
-30.79M-46.22M-49.06M-33.28M-23.79M
-30.79M-46.22M-49.06M-33.28M-23.79M
-30.05M-45.72M-48.56M-32.78M-23.29M
-26.40-52.40-56.40-43.20-54.80
-26.40-52.40-56.40-43.20-54.80
-26.40-52.40-56.40-43.20-54.80
-27.84M-42.57M-46.67M-31.05M-23.29M
-27.84M-42.57M-46.67M-31.05M-23.29M
736.00K500.00K500.00K500.00K500.00K
1.17M881.80K867.15K769.05K434.40K
1.17M881.80K867.15K769.05K434.40K